Key Statistics
Market Cap$368.94M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.85
52W High$105.00
52W Low$26.05
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees22
Price Performance
1 Week+1.90%
3 Month-10.69%
1 Year+59.38%
FinancialsAnnual · QuiverQuant
Revenue$429,039
Assets$7.35M
Liabilities$1.76M
Net Income$8.40M loss
About
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to developing proprietary therapies to improve clinical outcomes for cancer patients in the United States. The company is headquartered in Wilmette, Illinois.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze MNPR with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.